TREA

79314660 - CELLIXIR

Follow

Information

  • Trademark
  • 79314660
  • Serial Number
    79314660
  • Registration Number
    7616514
  • Filing Date
    March 12, 2021
    4 years ago
  • Registration Date
    December 24, 2024
    10 months ago
  • Transaction Date
    June 28, 2025
    4 months ago
  • Status Date
    December 24, 2024
    10 months ago
  • Published for Opposition Date
    November 05, 2024
    a year ago
  • Location Date
    December 23, 2024
    10 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    COUGHLAN, REBECCA
  • Attorney Docket Number
    SANT0336WOUS
    Attorney Name
    Mary Margaret L. O'Donnell
  • Owners
Information
Mark Drawing Code
4
Mark Identification
CELLIXIR
Case File Statements
  • GS0051: Pharmaceutical and veterinary preparations, namely, cells, tissues, and grafts engineering reagent for medical or veterinary purposes; diagnostic preparations for medical and veterinary use; living cells and cultures of microorganisms as well as protein arrays, synthetic peptides for the treatment of blood, genetic, and immune disorders and cancer and nucleic acid sequences and complexes of these molecules, namely, ribo-nucleo and desoxyribo-nucleo complexes, nucleo-proteo complexes for medical and veterinary use; living cells and cultures of microorganisms as well as proteins arrays, synthetic peptides and nucleic acids sequences and complexes of these molecules, namely, ribo-nucleo and desoxyribo-nucleo complexes, nucleo-proteo complexes for medical and clinical use for the treatment of genetic defects in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer; diagnostic preparations for medical and veterinary use, in particular for the diagnosis and analysis of genetic defects, viral and infectious diseases, cardiovascular diseases and cancer; living cells, cultures of microorganisms, and proteins arrays, synthetic peptides and nucleic acids sequences and complexes of these molecules, namely, ribo-nucleo and desoxyribo-nucleo complexes, nucleo-proteo complexes for medical and veterinary use, in particular for medical and clinical use for the treatment of genetic defects in gene therapy, viral and infectious diseases, cardiovascular diseases and cancer
  • GS0011: Chemicals and biochemical products for industrial and scientific use and not for medical or veterinary use, for transferring biological molecules into living cells and for integrating foreign nucleic acids into the genome of living cells; chemical and biochemical soluble substances and solutions for industrial use and not for medical or veterinary purposes, for the transfer of chemical or biological molecules into living cells and the integration of foreign nucleic acids into the genome of living cells; biological preparations for laboratory use, other than for medical and veterinary use; diagnostic preparations, other than for medical and veterinary use; peptide substrates, protein arrays and nucleic acids or complexes of these molecules, namely, ribo-nucleo and desoxyribo-nucleo complexes for clinical or medical laboratory use, for identifying genetic expression and protein location and integration of foreign nucleic acids into the genome of living cells; chemical and biochemical preparations for industrial and scientific use; chemical and biochemical soluble substances and solutions for industrial use and not for medical or veterinary purposes, for cellular and gene engineering and analysis in laboratories; Chemicals, namely, standard solutions and buffers used in analytical chemistry for transferring chemical and biological molecules into living cells, integration of foreign nucleic acids into the genome of living cells and transient production of proteins or nucleic acids; aqueous chemical and biochemical solutions containing nutrients for cultivating living cells for use in electroporation; biological cell and tissue cultures for laboratory use other than for medical and veterinary use; diagnostic reagents other than for medical and veterinary use; peptide substrates, protein array and nucleic acids or complexes of these molecules, namely, ribo-nucleo and desoxyribo-nucleo complexes, nucleo-proteo complexes for clinical or medical laboratory use, in particular for detecting and monitoring, and for integrating foreign nucleic acids into the genome of living cells and transient production of proteins; transfection reagents in the nature of chemical and biochemical reagents, used for transient production of proteins, other than for medical and veterinary use
Case File Event Statements
  • 7/1/2021 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 7/6/2021 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/10/2021 - 4 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 10/12/2021 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 4/25/2022 - 3 years ago
    16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 10/27/2021 - 4 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 10/28/2021 - 4 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 10/29/2021 - 4 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 10/29/2021 - 4 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 11/23/2021 - 3 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 4/25/2022 - 3 years ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/25/2022 - 3 years ago
    15 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 4/25/2022 - 3 years ago
    13 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 4/25/2022 - 3 years ago
    10 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 4/25/2022 - 3 years ago
    11 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/25/2022 - 3 years ago
    12 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 4/25/2022 - 3 years ago
    14 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/26/2022 - 3 years ago
    18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/12/2022 - 3 years ago
    19 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 6/12/2022 - 3 years ago
    20 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 6/12/2022 - 3 years ago
    21 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 12/7/2022 - 2 years ago
    22 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 12/7/2022 - 2 years ago
    23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/27/2022 - 2 years ago
    24 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 1/26/2023 - 2 years ago
    25 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 8/10/2023 - 2 years ago
    26 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 11/18/2023 - a year ago
    27 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 2/14/2024 - a year ago
    28 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 4/4/2024 - a year ago
    29 - FINAL REFUSAL WRITTEN Type: CNFR
  • 4/4/2024 - a year ago
    30 - FINAL REFUSAL E-MAILED Type: GNFR
  • 4/4/2024 - a year ago
    31 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 9/9/2024 - a year ago
    34 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/9/2024 - a year ago
    33 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/30/2024 - a year ago
    35 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 9/30/2024 - a year ago
    37 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/30/2024 - a year ago
    38 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/30/2024 - a year ago
    39 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/30/2024 - a year ago
    36 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 9/9/2024 - a year ago
    32 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 11/5/2024 - a year ago
    41 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/16/2024 - a year ago
    40 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/5/2024 - a year ago
    42 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/24/2024 - 10 months ago
    44 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 6/10/2025 - 5 months ago
    47 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 6/27/2025 - 4 months ago
    48 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 6/9/2025 - 5 months ago
    46 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 12/24/2024 - 10 months ago
    43 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/24/2025 - 7 months ago
    45 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR